Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori

References

• McCollKEClinical practice. Helicobacter pylori infectionN Engl J Med2010362171597160420427808
   PubMed Web of Science ®Google Scholar
• MalfertheinerPMegraudFO’MorainCCurrent concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut200756677278117170018
   PubMed Web of Science ®Google Scholar
• CheyWDWongBCAmerican College of Gastroenterology guideline on the management of Helicobacter pylori infectionAm J Gastroenterol200710281808182517608775
   PubMed Web of Science ®Google Scholar
• LamSKTalleyNJReport of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infectionJ Gastroenterol Hepatol19981311129737564
   PubMed Web of Science ®Google Scholar
• CoelhoLGLeon-BaruaRQuigleyEMLatin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE)Am J Gastroenterol200095102688269111051336
   PubMed Web of Science ®Google Scholar
• GisbertJPCalvetXGomollonFMonesJEradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus ConferenceMed Clin (Barc)2005125830131616159556
   PubMed Web of Science ®Google Scholar
• GrahamDYLuHYamaokaYA report card to grade Helicobacter pylori therapyHelicobacter200712427527817669098
   PubMed Web of Science ®Google Scholar
• SasakiMOgasawaraNUtsumiKChanges in 12-year first-line eradication rate of Helicobacter pylori based on triple therapy with proton pump inhibitor, amoxicillin and clarithromycinJ Clin Biochem Nutr2010471535820664731
   PubMed Web of Science ®Google Scholar
• LaineLFennertyMBOsatoMEsomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trialsAm J Gastroenterol200095123393339811151867
   PubMed Web of Science ®Google Scholar
• VakilNLanzaFSchwartzHBarthJSeven-day therapy for Helicobacter pylori in the United StatesAliment Pharmacol Ther20042019910715225176
   PubMed Web of Science ®Google Scholar
• JanssenMJVan OijenAHVerbeekALJansenJBDe BoerWAA systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazoleAliment Pharmacol Ther200115561362411328254
   PubMed Web of Science ®Google Scholar
• LaheijRJRossumLGJansenJBStraatmanHVerbeekALEvaluation of treatment regimens to cure Helicobacter pylori infection – a meta-analysisAliment Pharmacol Ther199913785786410383518
   PubMed Web of Science ®Google Scholar
• GrahamDYLuHYamaokaYTherapy for Helicobacter pylori infection can be improved: sequential therapy and beyondDrugs200868672573618416582
   PubMed Web of Science ®Google Scholar
• CalvetXGarciaNLopezTGisbertJPGeneERoqueMA meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAliment Pharmacol Ther200014560360910792124
   PubMed Web of Science ®Google Scholar
• FuccioLMinardiMEZagariRMGrilliDMagriniNBazzoliFMeta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradicationAnn Intern Med2007147855356217938394
   PubMed Web of Science ®Google Scholar
• GisbertJPCalvetXO’ConnorAMegraudFO’MorainCASequential therapy for Helicobacter pylori eradication: a critical reviewJ Clin Gastroenterol201044531332520054285
   PubMed Web of Science ®Google Scholar
• MoayyediPSequential regimens for Helicobacter pylori eradicationLancet200737095921010101217889226
   PubMed Web of Science ®Google Scholar
• ZulloADe FrancescoVHassanCMoriniSVairaDThe sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysisGut200756101353135717566020
   PubMed Web of Science ®Google Scholar
• JafriNSHornungCAHowdenCWMeta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatmentAnn Intern Med20081481292393118490667
   PubMed Web of Science ®Google Scholar
• TongJLRanZHShenJXiaoSDSequential therapy vs standard triple therapies for Helicobacter pylori infection: a meta-analysisJ Clin Pharm Ther2009341415319125902
   PubMed Web of Science ®Google Scholar
• GattaLVakilNLeandroGDi MarioFVairaDSequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and childrenAm J Gastroenterol20091041230693079 quiz 108019844205
   PubMed Web of Science ®Google Scholar
• CaselliMZulloAMaconiG“Cervia II Working Group Report 2006”: guidelines on diagnosis and treatment of Helicobacter pylori infection in ItalyDig Liver Dis200739878278917606419
   PubMedGoogle Scholar
• GisbertJPNyssenOPMcNichollAMeta-analysis of sequential vs standard triple therapy for Helicobacter pylori eradicationHelicobacter201116Suppl 113121435091
   PubMed Web of Science ®Google Scholar
• Molina-InfanteJPerez-GallardoBFernandez-BermejoMClinical trial: clarithromycin vs levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradicationAliment Pharmacol Ther201031101077108420180787
   PubMed Web of Science ®Google Scholar
• GaoXZQiaoXLSongWCWangXFLiuFStandard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradicationWorld J Gastroenterol201016344357436220818821
   PubMed Web of Science ®Google Scholar
• PaoluziOAViscontiEAndreiFTen and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerabilityJ Clin Gastroenterol201044426126620195162
   PubMed Web of Science ®Google Scholar
• RomanoMCuomoAGravinaAGEmpirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trialGut201059111465147020947881
   PubMed Web of Science ®Google Scholar
• GisbertJPSequential or concomitant therapy for Helicobacter pylori eradication?J Clin Gastroenterol20104465865920308919
   PubMed Web of Science ®Google Scholar
• VakilNHelicobacter pylori treatment: is sequential or quadruple therapy the answer?Rev Gastroenterol Disord200882778218641590
   PubMedGoogle Scholar
• GrahamDYLuHIs there a role for sequential in sequential anti-H. pylori therapy?Gastroenterology2006130619301931 author reply 193116697763
   PubMed Web of Science ®Google Scholar
• GisbertJPCalvetXReview article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pyloriAliment Pharmacol Ther201134660461721745241
   PubMed Web of Science ®Google Scholar
• GrahamDYShiotaniANew concepts of resistance in the treatment of Helicobacter pylori infectionsNat Clin Pract Gastroenterol Hepatol20085632133118446147
   PubMedGoogle Scholar
• TreiberGAmmonSSchneiderEKlotzUAmoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradicationHelicobacter19983154589546119
   PubMed Web of Science ®Google Scholar
• OkadaMOkiKShirotaniTA new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rateJ Gastroenterol19983356406459773927
   PubMed Web of Science ®Google Scholar
• PerriFClementeRFestaVRelationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infectionItal J Gastroenterol Hepatol19983021461509675647
   PubMed Web of Science ®Google Scholar
• MaconiGParenteFRussoAVagoLImbesiVBianchi PorroGDo some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?Am J Gastroenterol200196235936611232676
   PubMed Web of Science ®Google Scholar
• LaiYCYangJCHuangSHPre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcersWorld J Gastroenterol200410799199415052680
   PubMed Web of Science ®Google Scholar
• MoshkowitzMKonikoffFMPeledYHigh Helicobacter pylori numbers are associated with low eradication rate after triple therapyGut19953668458477615271
   PubMed Web of Science ®Google Scholar
• LutherJCheyWDSequential therapy for Helicobacter pylori: a two for one deal that’s worth the extra effort?Gastroenterology2009136272072219109960
   PubMed Web of Science ®Google Scholar
• MurakamiKFujiokaTOkimotoTSatoRKodamaMNasuMDrug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapyInt J Antimicrob Agents2002191677011814770
   PubMed Web of Science ®Google Scholar
• PaulsenITBrownMHSkurrayRAProton-dependent multidrug efflux systemsMicrobiol Rev19966045756088987357
   PubMedGoogle Scholar
• WebberMAPiddockLJThe importance of efflux pumps in bacterial antibiotic resistanceJ Antimicrob Chemother200351191112493781
   PubMed Web of Science ®Google Scholar
• RobertsMCResistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibioticsMol Biotechnol2004281476215456963
   PubMed Web of Science ®Google Scholar
• De FrancescoVMargiottaMZulloAClarithromycin-resistant genotypes and eradication of Helicobacter pyloriAnn Intern Med200614429410016418408
   PubMed Web of Science ®Google Scholar
• VairaDZulloAVakilNSequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trialAnn Intern Med2007146855656317438314
   PubMed Web of Science ®Google Scholar
• Summaries for patients. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradicationAnn Intern Med20071468I20
   Web of Science ®Google Scholar
• CalvetXTitoLCometRGarciaNCampoRBrulletEFour-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinida-zole and omeprazole to cure Helicobacter pylori infection: a pilot studyHelicobacter200051525610672052
   PubMed Web of Science ®Google Scholar
• CatalanoFBranciforteGCatanzaroRCipollaRBentivegnaCBrognaAHelicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimenAliment Pharmacol Ther200014101329133411012478
   PubMed Web of Science ®Google Scholar
• ChanKLZhouHNgDKTamPKA prospective study of a oneweek non-bismuth quadruple therapy for childhood Helicobacter pylori infectionJ Pediatr Surg20013671008101111431766
   PubMed Web of Science ®Google Scholar
• Molina-InfanteJPazos-PachecoCPerez-GallardoBEfficacy of 10-day non-bismuth quadruple “concomitant” regimen as first-line therapy for Helicobacter pylori infection in a setting with high rates of clarithromycin and dual clarithromycin and metronidazole resistanceHelicobacter201116Suppl 1133
   Google Scholar
• NagaharaAMiwaHOgawaKAddition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapyHelicobacter200052889310849057
   PubMed Web of Science ®Google Scholar
• NagaharaAMiwaHYamadaTKurosawaAOhkuraRSatoNFive-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infectionAliment Pharmacol Ther200115341742111207518
   PubMed Web of Science ®Google Scholar
• NevillePMEverettSLangworthyHThe optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimenAliment Pharmacol Ther199913449750110215734
   PubMed Web of Science ®Google Scholar
• OkadaMNishimuraHKawashimaMA new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcomeAliment Pharmacol Ther199913676977410383506
   PubMed Web of Science ®Google Scholar
• TreiberGWittigJAmmonSWalkerSvan DoornLJKlotzUClinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study)Arch Intern Med2002162215316011802748
   PubMed Web of Science ®Google Scholar
• WuDCHsuPIWuJYSequential and concomitant therapy with 4 drugs are equally effective for eradication of H. pylori infectionClin Gastroenterol Hepatol20108364119804842
   PubMed Web of Science ®Google Scholar
• GreenbergERAndersonGLMorganDR14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialLancet2011378979050751421777974
   PubMed Web of Science ®Google Scholar
• KongchayanunCMahachaiVPornthisarnBAmornsawadwattanaSVilaichoneRKEfficacy of 10-day and 5-day concomitant therapy for Helicobacter pylori eradication in Thai patients with non ulcer dyspepsiaGastroenterology2011140Suppl 187921111741
   PubMed Web of Science ®Google Scholar
• KimSYLeeSWKwonBSComparative study of Helicobacter pylori eradication rates of 5-day quadruple “Concomitant” therapy and 7-day standard triple therapyGastroenterology2011140Suppl 1878
   Google Scholar
• TorosABInceATKesiciBSaglamMPolatZUygunAA new modified concomitant therapy for Helicobacter pylori eradication in TurkeyHelicobacter201116322522821585608
   PubMed Web of Science ®Google Scholar
• KwonBSParkEBLeeDHEffectiveness of 5-day and 7-day quadruple “concomitant” therapy regimen for Helicobacter pylori infection in KoreaHelicobacter201116Suppl 1135
   Google Scholar
• MoonBLimHLeeSHanKChungJLeeYEfficacy of concomitant nonbithmuth-based quadruple therapy as first-line treatment for eradication of Helicobacter pyloriHelicobacter201116Suppl 113121435091
   PubMed Web of Science ®Google Scholar
• ChoiCLeeDChonIConcomitant therapy was more effective than ppi-base triple therapy in Korea: a preliminary reportHelicobacter201116Suppl 1136
   Google Scholar
• GumurduluYSerinEOzerBLow eradication rate of Helicobacter pylori with triple 7–14 days and quadriple therapy in TurkeyWorld J Gastroenterol200410566867114991935
   PubMed Web of Science ®Google Scholar
• Perez AldanaLKatoMNakagawaSThe relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistanceHelicobacter20027530630912390210
   PubMed Web of Science ®Google Scholar
• VakilNH. pylori treatment: new wine in old bottles?Am J Gastroenterol20091041263019098845
   PubMed Web of Science ®Google Scholar
• MegraudFH. pylori antibiotic resistance: prevalence, importance, and advances in testingGut20045391374138415306603
   PubMed Web of Science ®Google Scholar
• MegraudFHelicobacter pylori and antibiotic resistanceGut20075611150217938430
   PubMed Web of Science ®Google Scholar
• FischbachLEvansELMeta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pyloriAliment Pharmacol Ther200726334335717635369
   PubMed Web of Science ®Google Scholar
• GisbertJPPajaresJMReview article: Helicobacter pylori “rescue” regimen when proton pump inhibitor-based triple therapies failAliment Pharmacol Ther20021661047105712030945
   PubMed Web of Science ®Google Scholar
• GisbertJPPajaresJMHelicobacter pylori “rescue” therapy after failure of two eradication treatmentsHelicobacter200510536337216181345
   PubMed Web of Science ®Google Scholar
• VakilNVairaDSequential therapy for Helicobacter pylori: time to consider making the switch?JAMA2008300111346134718799448
   PubMed Web of Science ®Google Scholar
• HoubenMHvan de BeekDHensenEFCraenAJRauwsEATytgatGNA systematic review of Helicobacter pylori eradication therapy – the impact of antimicrobial resistance on eradication ratesAliment Pharmacol Ther19991381047105510468680
   PubMed Web of Science ®Google Scholar
• ZulloAVairaDVakilNHigh eradication rates of Helicobacter pylori with a new sequential treatmentAliment Pharmacol Ther200317571972612641522
   PubMed Web of Science ®Google Scholar
• Molina-InfanteJPazos-PachecoCVinagre-RodriguezGNon-bismuth quadruple “concomitant” therapy versus standard triple therapy for clarithromycin-susceptible H. pylori and versus quadruple “sequential” therapy for clarithromycin-resistant H. pyloriHelicobacter201116Suppl 1135
   Google Scholar
• O’MorainCAO’ConnorJPIs sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection?Nat Clin Pract Gastroenterol Hepatol2009618918838974
   PubMedGoogle Scholar
• EssaASKramerJRGrahamDYTreiberGMeta-analysis: four-drug, three-antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradicationHelicobacter200914210911819298338
   PubMed Web of Science ®Google Scholar
• CalvetXGeneELopezTGisbertJPWhat is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysisAliment Pharmacol Ther20011571067107611421884
   PubMed Web of Science ®Google Scholar
• de BoerWAKuipersEJKustersJGSequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?Dig Liver Dis200436531131415191198
   PubMedGoogle Scholar
• LiouJMLinJTChangCYLevofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover designGut201059557257820427390
   PubMed Web of Science ®Google Scholar
• PeitzUSulligaMWolleKHigh rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized studyAliment Pharmacol Ther200216231532411860415
   PubMed Web of Science ®Google Scholar
• BealesILEfficacy of Helicobacter pylori eradication therapies: a single centre observational studyBMC Gastroenterol20011711545677
   PubMedGoogle Scholar
• GisbertJPMorenaFSystematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failureAliment Pharmacol Ther2006231354416393278
   PubMed Web of Science ®Google Scholar
• GisbertJPBermejoFCastro-FernandezMSecond-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patientsAm J Gastroenterol20081031717617764498
   PubMed Web of Science ®Google Scholar
• GisbertJPCastro-FernandezMBermejoFThird-line rescue therapy with levofloxacin after two H. pylori treatment failuresAm J Gastroenterol2006101224324716454825
   PubMed Web of Science ®Google Scholar
• ZulloADe FrancescoVHassanCSecond-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot studyTherapy20063251254
   Google Scholar
• PernaFZulloARicciCHassanCMoriniSVairaDLevofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistanceDig Liver Dis200739111001100517889627
   PubMedGoogle Scholar
• GisbertJPVinagre-RodriguezGMarinACMolina-InfanteJSecond-line rescue triple therapy with levofloxacin after quadruple nonbismuth “sequential” or “concomitant” treatment failureHelicobacter201116Suppl 1135
   Google Scholar
• ZulloAHassanCMoriniSSequential therapy for H. pylori: an ‘aberrant’ therapy ready for general useDig Liver Dis20043612852853 author reply 85315646435
   PubMedGoogle Scholar
• ScaccianoceGHassanCPanareseAPiglionicaDMoriniSZulloAHelicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimenCan J Gastroenterol200620211311716482238
   PubMed Web of Science ®Google Scholar
• ShehadaSSrugoIShaoulRFailure of sequential therapy to eradicate Helicobacter pylori in previously treated subjectsHelicobacter200712664564718001409
   PubMed Web of Science ®Google Scholar
• GisbertJPRescue therapy after Helicobacter pylori eradication failureGastroenterol Hepatol2011342899921371619
   PubMed Web of Science ®Google Scholar